{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:36:48Z","timestamp":1791689808596,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Accumulating evidence suggest that Epstein-Barr virus (EBV) is crucial in the development of multiple sclerosis (MS), with inadequate infection control possibly contributing to disease onset. Past infectious mononucleosis (IM) has been found to interact with smoking, obesity, and sun exposure. We aimed to investigate potential interactions between a history of IM and the following risk factors for MS: passive smoking, alcohol consumption, fish consumption, vitamin D status, adolescent sleep duration and sleep quality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We analyzed data from a Swedish population-based case-control study (3128 cases and 5986 controls). Subjects were categorized based on IM status and each exposure variable and compared regarding MS risk by calculating odds ratios (OR) with 95% confidence intervals (CI) using logistic regression models. Additive interaction between aspects of IM status and each exposure was assessed by calculating the attributable proportion due to interaction (AP) with 95% CI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The OR of developing MS among those who reported a history of IM was 1.86 (95% CI 1.63\u20132.12), compared with those who had not suffered from IM. We observed synergistic effects between a history of IM and each exposure variable with respect to risk of MS, with significant APs ranging between 0.20 and 0.35.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The concept of EBV infection as a crucial factor for MS gains further support from our findings suggesting that MS risk factors synergize with a history of IM in disease development. Targeting modifiable MS risk factors that impede effective immune regulation of the virus holds promise for preventive interventions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s10654-025-01212-1","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T20:24:42Z","timestamp":1741119882000},"page":"339-346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of lifestyle factors post-infectious mononucleosis on multiple sclerosis risk"],"prefix":"10.1007","volume":"40","author":[{"given":"Eva","family":"Johansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Alfredsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6612-4749","authenticated-orcid":false,"given":"Anna Karin","family":"Hedstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"1212_CR1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375:296\u2013301.","journal-title":"Science"},{"key":"1212_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/1352458512449682","volume":"19","author":"J Pakpoor","year":"2013","unstructured":"Pakpoor J, Disanto G, Gerber JE, Dobson R, Meier UC, Giovannoni G, et al. The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis. Mult Scler. 2013;19:162\u20136.","journal-title":"Mult Scler"},{"key":"1212_CR3","unstructured":"Rothman KJ, Greenland S, Lash TL. Modern Epidemiology, 3rd edition, Philadelphia: Lippincott Wolliams & Wilkins (2008)."},{"key":"1212_CR4","doi-asserted-by":"publisher","first-page":"1212676","DOI":"10.3389\/fimmu.2023.1212676","volume":"14","author":"AK Hedstr\u00f6m","year":"2023","unstructured":"Hedstr\u00f6m AK. Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection. Front Immunol. 2023;14:1212676.","journal-title":"Front Immunol"},{"key":"1212_CR5","doi-asserted-by":"publisher","first-page":"e12496","DOI":"10.1371\/journal.pone.0012496","volume":"5","author":"AE Handel","year":"2010","unstructured":"Handel AE, Williamson AJ, Disanto G, Handunnetthi L, Giovannoni G, Ramagopalan SV. An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS ONE. 2010;5:e12496.","journal-title":"PLoS ONE"},{"key":"1212_CR6","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1177\/1352458513477231","volume":"19","author":"G Disanto","year":"2013","unstructured":"Disanto G, Hall C, Lucas R, Ponsonby AL, Berlanga-Taylor AJ, Giovannoni G, et al. Assessing interactions between HLA-DRB1*15 and infectious mononucleosis on the risk of multiple sclerosis. Mult Scler. 2013;19:1355\u20138.","journal-title":"Mult Scler"},{"key":"1212_CR7","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1212\/01.wnl.0000294325.63006.f8","volume":"70","author":"PL De Jager","year":"2008","unstructured":"De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, Ascherio A. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology. 2008;70:1113\u20138.","journal-title":"Neurology"},{"key":"1212_CR8","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1136\/jnnp-2020-325676","volume":"92","author":"AK Hedstr\u00f6m","year":"2021","unstructured":"Hedstr\u00f6m AK, Hillert J, Brenner N, Butt J, Waterboer T, Strid P, et al. DRB1-environment interactions in multiple sclerosis etiology: results from two Swedish case-control studies. J Neurol Neurosurg Psychiatry. 2021;92:717\u201322.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1212_CR9","doi-asserted-by":"crossref","unstructured":"Salzer J, Stenlund H, Sundstr\u00f6m P. The interaction between smoking and Epstein-Barr virus as multiple sclerosis risk factors may depend on age. Mult Scler (, Huang J, Brenner N, Butt J, Hillert J, Waterboer T et al. Smoking and Epstein-Barr virus infection in multiple sclerosis development. Sci Rep (2020) 10:10960.","DOI":"10.1038\/s41598-020-67883-w"},{"key":"1212_CR10","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/ene.12620","volume":"22","author":"AK Hedstr\u00f6m","year":"2015","unstructured":"Hedstr\u00f6m AK, Bomfim IL, Hillert J, Olsson T, Alfredsson L. Obesity interacts with infectious mononucleosis in risk of multiple sclerosis. Eur J Neurol. 2015;22:578\u2013e38.","journal-title":"Eur J Neurol"},{"key":"1212_CR11","doi-asserted-by":"publisher","first-page":"4146","DOI":"10.1111\/ene.15082","volume":"28","author":"AK Hedstr\u00f6m","year":"2021","unstructured":"Hedstr\u00f6m AK, Huang J, Brenner N, Butt J, Kockum I, Waterboer T, et al. Low sun exposure acts synergistically with high Epstein-Barr nuclear antigen 1 (EBNA-1) antibody levels in multiple sclerosis etiology. Eur J Neurol. 2021;28:4146\u201352.","journal-title":"Eur J Neurol"},{"key":"1212_CR12","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald criteria. Ann Neurol. 2005;58:840\u20136.","journal-title":"Ann Neurol"},{"key":"1212_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292\u2013302.","journal-title":"Ann Neurol"},{"key":"1212_CR14","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nri803","volume":"2","author":"M Sopori","year":"2002","unstructured":"Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol. 2002;2:372\u20137. https:\/\/doi.org\/10.1038\/nri803.","journal-title":"Nat Rev Immunol"},{"key":"1212_CR15","doi-asserted-by":"publisher","first-page":"J258","DOI":"10.1016\/j.jaut.2009.12.003","volume":"34","author":"Y Arnson","year":"2010","unstructured":"Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun. 2010;34:J258\u2013265.","journal-title":"J Autoimmun"},{"key":"1212_CR16","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/infdis\/jiy542","volume":"219","author":"Y He","year":"2019","unstructured":"He Y, Liao X, Xue W, Xu YF, Xu FH, Li FF, et al. Association between environmental factors and oral Epstein-Barr virus DNA loads: a multicenter cross-sectional study in China. J Infect Dis. 2019;219:400\u20139.","journal-title":"J Infect Dis"},{"key":"1212_CR17","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1002\/cam4.2083","volume":"8","author":"T Hu","year":"2019","unstructured":"Hu T, Lin C, Xie S, Chen GH, Lu YQ, Ling W, et al. Smoking can increase nasopharyngeal carcinoma risk by repeatedly reactivation Epstein-Barr virus: an analysis of a prospective study in Southern China. Cancer Med. 2019;8:2561\u201371.","journal-title":"Cancer Med"},{"key":"1212_CR18","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1093\/jnci\/djs320","volume":"104","author":"FH Xu","year":"2012","unstructured":"Xu FH, Xiong D, Xu YF, Cao SM, Xue WQ, Qin HD, et al. An epidemiological and molecular study of the relationship between smoking, risk of nasopharyngeal carcinoma, and Epstein-Barr virus activation. J Natl Cancer Inst. 2012;104:1396\u2013410.","journal-title":"J Natl Cancer Inst"},{"key":"1212_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1465-9921-10-108","volume":"10","author":"CA Brandsma","year":"2009","unstructured":"Brandsma CA, Hylkema MN, Geerlings M, van Geffen WH, Postma DS, Timens W, et al. Increased levels of (class switched) memory B cells in peripheral blood of current smokers. Respir Res. 2009;10:108.","journal-title":"Respir Res"},{"key":"1212_CR20","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nature11337","volume":"488","author":"F Odoardi","year":"2012","unstructured":"Odoardi F, Sie C, Streyl K, Ulaganathan VK, Schl\u00e4ger C, Lodygin D, et al. T cells become licensed in the lung to enter the central nervous system. Nature. 2012;488:675\u20139.","journal-title":"Nature"},{"key":"1212_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/intimm\/dxu147","volume":"27","author":"A Waddell","year":"2015","unstructured":"Waddell A, Zhao J, Cantorna MT. NKT cells can help mediate the protective effects of 1,25-dihydroxyvitamin D3 in experimental autoimmune encephalomyelitis in mice. Int Immunol. 2015;27:237\u201344. https:\/\/doi.org\/10.1093\/intimm\/dxu147.","journal-title":"Int Immunol"},{"key":"1212_CR22","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1096\/fj.04-3284com","volume":"19","author":"AF Gombart","year":"2005","unstructured":"Gombart AF, Borregaard N, Koeffler HP. Human Cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and i strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D2. FASEB J. 2005;19:1067\u201377.","journal-title":"FASEB J"},{"key":"1212_CR23","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1177\/1352458513483888","volume":"19","author":"J Salzer","year":"2013","unstructured":"Salzer J, Nystr\u00f6m M, Hallmans G, Stenlund H, Wadell G, Sundstr\u00f6m P. Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples. Mult Scler. 2013;19:1587\u201391.","journal-title":"Mult Scler"},{"key":"1212_CR24","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1111\/ene.12986","volume":"23","author":"S Wergeland","year":"2016","unstructured":"Wergeland S, Myhr KM, L\u00f8ken-Armsrud KI, Beiske AG, Bjerve S, Hovdal H, et al. Vitamin D, HLA-DRB1 and Epstein\u2013Barr virus antibody levels in a prospective cohort of multiple sclerosis patients. Eur J Neurol. 2016;23:1064\u201370.","journal-title":"Eur J Neurol"},{"key":"1212_CR25","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41588-018-0102-3","volume":"50","author":"JB Harley","year":"2018","unstructured":"Harley JB, Chen XX, Pujato M, Miller D, Maddox A, Forney C, et al. Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat Genet. 2018;50:699\u2013707.","journal-title":"Nat Genet"},{"key":"1212_CR26","doi-asserted-by":"publisher","first-page":"e0119605","DOI":"10.1371\/journal.pone.0119605","volume":"10","author":"VAG Ricigliano","year":"2015","unstructured":"Ricigliano VAG, Handel AE, Sandve GK, Annibali V, Ristori G, Mechelli R, et al. EBNA2 binds to genomic intervals associated with multiple sclerosis and overlaps with vitamin D receptor occupancy. PLoS ONE. 2015;10:e0119605.","journal-title":"PLoS ONE"},{"key":"1212_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1136\/jnnp-2022-330123","volume":"94","author":"T \u00c5kerstedt","year":"2023","unstructured":"\u00c5kerstedt T, Olsson T, Alfredsson L, Hedstr\u00f6m AK. Insufficient sleep during adolescence and risk of multiple sclerosis: results from a Swedish case-control study. J Neurol Neurosurg Psychiatry. 2023;94:331\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1212_CR28","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1017\/S0007114507838049","volume":"98","author":"J Romeo","year":"2007","unstructured":"Romeo J, W\u00e4rnberg J, Nova E, et al. Moderate alcohol consumption and the immune system. Br J Nutr. 2007;98:S111\u20135.","journal-title":"Br J Nutr"},{"key":"1212_CR29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/MCO.0b013e3283620616","volume":"16","author":"PC Calder","year":"2013","unstructured":"Calder PC. Long chain fatty acids and gene expression in inflammation and immunity. Curr Opin Clin Nutr Metab Care. 2013;16:425\u201333.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1212_CR30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/HP.0000000000000742","volume":"114","author":"P Gies","year":"2018","unstructured":"Gies P, van Deventer E, Green AC, Sinclair C, Tinker R. Review of the global solar UV index 2015 workshop report. Health Phys. 2018;114:84\u201390.","journal-title":"Health Phys"},{"key":"1212_CR31","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.3390\/ijms25094942","volume":"25","author":"V Abrignani","year":"2024","unstructured":"Abrignani V, Salvo A, Pacinella G, et al. The mediterranean diet, its Microbiome connections, and cardiovascular health: a narrative review. Int J Mol Sci. 2024;25:4942.","journal-title":"Int J Mol Sci"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-025-01212-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10654-025-01212-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-025-01212-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T05:24:18Z","timestamp":1749014658000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10654-025-01212-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1212"],"URL":"https:\/\/doi.org\/10.1007\/s10654-025-01212-1","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"EJ has nothing to disclose. TO has received lecture\/advisory board honoraria, and unrestricted MS research grants from Biogen, Novartis, Sanofi and Merck. LA reports lecture honoraria from Merck and grants from Swedish Research Council, grants from Swedish Research Council for Health Working Life and Welfare, grants from Swedish Brain Foundation, during the conduct of the study. AKH has nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}